Left ventricular hypertrophy is an important risk factor in cardiovascular disease and
echocardiography has been widely used for diagnosis. Although an adequate methodologic …

Left ventricular hypertrophy (LVH) and diastolic dysfunction (CHF-D) are the early
manifestations of cardiovascular target organ damage in patients with arterial hypertension …

Background: Although left ventricular hypertrophy (LVH) is a strong predictor of mortality in
patients with end-stage renal disease, few studies are available before the start of dialysis …

The goal of this study was to determine the role of estrogen receptor subtypes in the
development of pressure overload hypertrophy in mice. Epidemiological studies have …

Objective Few data are available comparing the effects of monotherapy and combination
therapy on target organ damage. The PICXEL study compared the efficacy of a strategy …

Left ventricular hypertrophy (LVH) is a potent, independent predictor of cardiovascular
events, particularly in hypertension, in which it dramatically increases the risk of stroke …

Aims/hypothesis Patients with type 2 diabetes mellitus are at greater cardiovascular risk than
the general population. Although it is widely acknowledged that diabetes is a risk factor for …

Obstructive sleep apnoea syndrome (OSAS) might be a cause of heart failure. The present
study aimed to assess left ventricular mass and myocardial performance index (MPI) in …

The role that dietary lipid and plasma fatty acid concentration play in the development of
cardiac hypertrophy in response to hypertension is not clear. 2. In the present study, we …

Metabolic remodelling in the heart occurs in response to chronically altered workload and
substrate availability. Recently the importance of the metabolic remodelling processes …